Skip to main content

Featured

NATO Tensions Spike as Trump Blasts Allies Over Iran Conflict

The US president complained NATO countries did not want to join the fight against Iran, yet still complain about high oil prices. U.S. President Donald Trump sharply criticized NATO allies on Friday, accusing them of failing to support the U.S.-Israel military campaign against Iran and branding the alliance “cowards. Rising Friction Within the Alliance Speaking from the Oval Office, Trump argued that NATO partners were unwilling to contribute meaningfully to the conflict, despite benefiting from U.S. security guarantees. He declared on social media that “without the U.S.A., NATO IS A PAPER TIGER,” warning that Washington would “remember” the lack of support.  Strategic Stakes The criticism comes as tensions escalate across the Middle East, with the U.S. and Israel engaged in active military operations against Iran. Trump has repeatedly urged NATO members to take a more assertive role, particularly in securing strategic waterways such as the Strait of Hormuz.  Broader Hum...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment